RAD51D and neoplasm: On the other hand, there was no significant correlation between the expression levels of RAD51D or XRCC2 and lymphatic vessel invasion, vascular invasion, tumor size, p53 expression, CerbB2 expression, or Ki‐67 expression (Figure S1).